RA
IMNN icon

Royce & Associates’s Imunon IMNN Stock Holding History

Royce & Associates’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-61
Closed -$280K – 1142
2015
Q3 		$280K Sell
61
-17
-22% -$101K ﹤0.01% 1087
2015
Q2 		$501K Hold
78
– – ﹤0.01% 1084
2015
Q1 		$569K Sell
78
-7
-8% -$48.7K ﹤0.01% 1072
2014
Q4 		$543K Hold
85
– – ﹤0.01% 1129
2014
Q3 		$690K Hold
85
– – ﹤0.01% 1177
2014
Q2 		$809K Hold
85
– – ﹤0.01% 1172
2014
Q1 		$786K Buy
85
+72
+554% +$749K ﹤0.01% 1179
2013
Q4 		$138K Hold
13
– – ﹤0.01% 1335
2013
Q3 		$184K Hold
13
– – ﹤0.01% 1307
2013
Q2 		$163K Buy
+13
New +$181K ﹤0.01% 1307

Other funds holding IMNN

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Royce & Associates's IMNN Position: Q4 2015 in Review

Royce & Associates sold out of Imunon (IMNN) in Q4 2015, closing a stake of 61 shares — an estimated $280K sold.

Royce & Associates first reported a position in IMNN in Q2 2013 and held it in 10 quarters. The position peaked at $809K in Q2 2014. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2015.

  • Royce & Associates reported no remaining Imunon position as of Q4 2015 after selling out during the quarter.
  • Royce & Associates sold 61 Imunon shares in Q4 2015, an estimated $280K.
  • Royce & Associates first reported a position in Imunon in Q2 2013 and held it in 10 quarters.
  • Royce & Associates's Imunon position peaked at $809K in Q2 2014.
  • 25 funds tracked by Wall St. Rank held Imunon as of Q4 2015.

Based on Royce & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.